Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Collegium Pharmaceutical Inc
354Current price
27.6 EUR
-0.8 EUR (-2.82%)
Last closed
30.27 USD
Company
www.collegiumpharma.com
ISIN
US19459J1043
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
1 037 166 400 USD
Yield for 12 month
+17.75 %
1Y
3Y
5Y
10Y
15Y
354
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
43.25 USDP/E ratio
13.7436Dividend Yield
–Current Year
+566 767 000 USD
Last Year
+463 933 000 USD
Current Quarter
+159 301 000 USD
Last Quarter
+145 276 000 USD
Current Year
+326 169 000 USD
Last Year
+209 488 000 USD
Current Quarter
+96 794 000 USD
Last Quarter
+90 806 000 USD
Key Figures 354
1 year
3 years
5 years
10 years
EBITDA
365 820 992 USD
Operating Margin TTM
PE Ratio
13.7436
Return On Assets TTM
9.68 %
PEG Ratio
–
Return On Equity TTM
42.89 %
Wall Street Target Price
43.25 USD
Revenue TTM
599 244 992 USD
Book Value
7.27 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
16.5 %
Dividend Yield
–
Gross Profit TTM
345 743 000 USD
Earnings per share
2.34 USD
Diluted Eps TTM
2.34 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-49.5 %
Profit Margin
14.78 %
Dividend Analytics 354
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 354
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 354
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
13.7436
Forward PE
4.8008
Enterprise Value Revenue
2.9898
Price Sales TTM
1.7308
Enterprise Value EBITDA
5.1673
Price Book MRQ
4.4271
Financials 354
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 354
For 52 weeks
24.61 USD
42.29 USD
50 Day MA
37.07 USD
Shares Short Prior Month
5 936 252
200 Day MA
35.53 USD
Short Ratio
13.27
Shares Short
6 147 408
Short Percent
23.67 %
BeatStart